Report cover image

Antibiotics Market by Action Mechanism (Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors), Drug Class (Aminoglycosides, Carbapenem, Cephalosporin), Spectrum, Category, Application, Route of Administration, Distribution Cha

Publisher 360iResearch
Published Jan 15, 2024
Length 192 Pages
SKU # IRE18418391

Description

Antibiotics Market by Action Mechanism (Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors), Drug Class (Aminoglycosides, Carbapenem, Cephalosporin), Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2024-2030


The Antibiotics Market size was estimated at USD 43.08 billion in 2023 and expected to reach USD 45.74 billion in 2024, at a CAGR 6.81% to reach USD 68.35 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antibiotics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antibiotics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antibiotics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., Bausch Health Companies, Inc., Bayer AG, Bristol-Myers Squibb Company, Cadila Healthcare Ltd., Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Glenmark Pharmaceuticals Limited, Hetero Healthcare, Johnson & Johnson Services, Inc., KYORIN Holdings, Inc., Lupin Limited, Melinta Therapeutics, Inc., Merck & Co., Inc., MerLion Pharmaceuticals GmbH, Mylan N.V. by Viatris, Novartis International AG, Pfizer Inc., Sanofi S.A., Shionogi & Co., Ltd., Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Antibiotics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Action Mechanism

Cell Wall Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • Mycolic Acid Inhibitors
  • Protein Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Drug Class

    Aminoglycosides
  • Carbapenem
  • Cephalosporin
  • Fluoroquinolone
  • Macrolides
  • Penicillin
  • Sulfonamides
  • Spectrum

    Broad-spectrum Antibiotics
  • Narrow-spectrum Antibiotics
  • Category

    Branded Antibiotics
  • Generic Antibiotics
  • Application

    Ear Infection
  • Gastrointestinal Infections
  • Respiratory Infections
  • Septicemia
  • Skin Infections
  • Urinary Tract Infections
  • Route of Administration

    Oral
  • Parenteral
  • Distribution Channel

    Offline
  • Online
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Antibiotics Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antibiotics Market?
    3. What are the technology trends and regulatory frameworks in the Antibiotics Market?
    4. What is the market share of the leading vendors in the Antibiotics Market?
    5. Which modes and strategic moves are suitable for entering the Antibiotics Market?


    Note: PDF & Excel + Online Access - 1 Year

    • Table of Contents

    192 Pages
    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Antibiotics Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
    5.1.1.2. Inclination toward early diagnosis and treatment of diseases
    5.1.1.3. Rise in the number of clinical trials for the development of novel antibiotics
    trials
    5.1.2. Restraints
    5.1.2.1. Concerns associated with antibiotics resistance
    5.1.3. Opportunities
    5.1.3.1. Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
    5.1.3.2. Growing in R&D and investments for the development of new drugs
    5.1.4. Challenges
    5.1.4.1. Side effects caused by the usage of antibiotic drugs
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Antibiotics Market, by Action Mechanism
    6.1. Introduction
    6.2. Cell Wall Synthesis Inhibitors
    6.3. DNA Synthesis Inhibitors
    6.4. Mycolic Acid Inhibitors
    6.5. Protein Synthesis Inhibitors
    6.6. RNA Synthesis Inhibitors
    7. Antibiotics Market, by Drug Class
    7.1. Introduction
    7.2. Aminoglycosides
    7.3. Carbapenem
    7.4. Cephalosporin
    7.5. Fluoroquinolone
    7.6. Macrolides
    7.7. Penicillin
    7.8. Sulfonamides
    8. Antibiotics Market, by Spectrum
    8.1. Introduction
    8.2. Broad-spectrum Antibiotics
    8.3. Narrow-spectrum Antibiotics
    9. Antibiotics Market, by Category
    9.1. Introduction
    9.2. Branded Antibiotics
    9.3. Generic Antibiotics
    10. Antibiotics Market, by Application
    10.1. Introduction
    10.2. Ear Infection
    10.3. Gastrointestinal Infections
    10.4. Respiratory Infections
    10.5. Septicemia
    10.6. Skin Infections
    10.7. Urinary Tract Infections
    11. Antibiotics Market, by Route of Administration
    11.1. Introduction
    11.2. Oral
    11.3. Parenteral
    12. Antibiotics Market, by Distribution Channel
    12.1. Introduction
    12.2. Offline
    12.3. Online
    13. Americas Antibiotics Market
    13.1. Introduction
    13.2. Argentina
    13.3. Brazil
    13.4. Canada
    13.5. Mexico
    13.6. United States
    14. Asia-Pacific Antibiotics Market
    14.1. Introduction
    14.2. Australia
    14.3. China
    14.4. India
    14.5. Indonesia
    14.6. Japan
    14.7. Malaysia
    14.8. Philippines
    14.9. Singapore
    14.10. South Korea
    14.11. Taiwan
    14.12. Thailand
    14.13. Vietnam
    15. Europe, Middle East & Africa Antibiotics Market
    15.1. Introduction
    15.2. Denmark
    15.3. Egypt
    15.4. Finland
    15.5. France
    15.6. Germany
    15.7. Israel
    15.8. Italy
    15.9. Netherlands
    15.10. Nigeria
    15.11. Norway
    15.12. Poland
    15.13. Qatar
    15.14. Russia
    15.15. Saudi Arabia
    15.16. South Africa
    15.17. Spain
    15.18. Sweden
    15.19. Switzerland
    15.20. Turkey
    15.21. United Arab Emirates
    15.22. United Kingdom
    16. Competitive Landscape
    16.1. FPNV Positioning Matrix
    16.2. Market Share Analysis, By Key Player
    16.3. Competitive Scenario Analysis, By Key Player
    17. Competitive Portfolio
    17.1. Key Company Profiles
    17.1.1. Abbott Laboratories
    17.1.2. Amneal Pharmaceuticals LLC
    17.1.3. Astellas Pharma, Inc.
    17.1.4. Bausch Health Companies, Inc.
    17.1.5. Bayer AG
    17.1.6. Bristol-Myers Squibb Company
    17.1.7. Cadila Healthcare Ltd.
    17.1.8. Dr. Reddy's Laboratories
    17.1.9. Eli Lilly and Company
    17.1.10. F. Hoffmann-La Roche AG
    17.1.11. Glenmark Pharmaceuticals Limited
    17.1.12. Hetero Healthcare
    17.1.13. Johnson & Johnson Services, Inc.
    17.1.14. KYORIN Holdings, Inc.
    17.1.15. Lupin Limited
    17.1.16. Melinta Therapeutics, Inc.
    17.1.17. Merck & Co., Inc.
    17.1.18. MerLion Pharmaceuticals GmbH
    17.1.19. Mylan N.V. by Viatris
    17.1.20. Novartis International AG
    17.1.21. Pfizer Inc.
    17.1.22. Sanofi S.A.
    17.1.23. Shionogi & Co., Ltd.
    17.1.24. Sun Pharmaceutical Industries Limited
    17.1.25. Teva Pharmaceutical Industries Ltd.
    17.2. Key Product Portfolio
    18. Appendix
    18.1. Discussion Guide
    18.2. License & Pricing
    FIGURE 1. ANTIBIOTICS MARKET RESEARCH PROCESS
    FIGURE 2. ANTIBIOTICS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ANTIBIOTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ANTIBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ANTIBIOTICS MARKET DYNAMICS
    FIGURE 7. ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2030 (%)
    FIGURE 8. ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
    FIGURE 10. ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2023 VS 2030 (%)
    FIGURE 12. ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
    FIGURE 14. ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    FIGURE 16. ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
    FIGURE 18. ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
    FIGURE 20. ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 22. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 23. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 24. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 25. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 26. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 27. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 28. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 29. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 30. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us